Ligand Pharmaceuticals

About:

Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies.

Website: http://www.ligand.com

Twitter/X: Ligand_LGND

Top Investors: Venrock

Description:

Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Ligand business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand's goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified, and lower-risk business than a typical biotech company. Ligand business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation, and partnering. Ligand partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management, and commercialization) to ultimately generate Ligand revenue.

Total Funding Amount:

$875M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

San Diego, California, United States

Founded Date:

1987-09-01

Contact Email:

jobs(AT)ligand.com

Founders:

Brook Byers

Number of Employees:

51-100

Last Funding Date:

2018-05-16

IPO Status:

Public

© 2025 bioDAO.ai